Nanjing Zenshine Pharmaceuticals Co., Ltd. announced a placement of common shares for gross proceeds of CNY 60 million on September 18, 2023. The transaction will include participation from new investor, Hubei Jumpcan Pharmaceutical Co., Ltd. for 3.40520% stake. CNY 506,693 will be included in the registered capital.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.56 CNY | -0.58% | -4.97% | +25.87% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.87% | 5.05B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.83% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it expects to receive CNY 60 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd.